“Pseudoephedrine and Risk of Posterior Reversible Encephalopathy Syndrome (PRES): Case Report in an Adult Patient”, Ictus, vol. 5, no. 1, p. e08032505003, Mar. 2025, doi: 10.5281/zenodo.15886568.